CONMED | CNMD - Assets


CONMED reported $2.32B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
3M USD 37.73B 122M Dec/2025
Abbott USD 84.18B 182M Sep/2025
AtriCure USD 635.44M 26.59M Sep/2025
Avanos Medical USD 1.07B 28.7M Sep/2025
Baxter International USD 21.07B 21M Sep/2025
Becton, Dickinson and Co. USD 55.32B 423M Sep/2025
Boston Scientific USD 42.71B 1.15B Sep/2025
CONMED USD 2.32B 5.97M Sep/2025
Cooper Companies USD 12.39B 18.1M Sep/2025
Dexcom USD 7.5B 173M Sep/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Globus Medical USD 5.1B 134.55M Sep/2025
Hologic USD 9.18B 165.8M Dec/2025
Insulet USD 3.03B 439.9M Sep/2025
Integra LifeSciences USD 3.65B 21.45M Sep/2025
Intuitive Surgical USD 20.46B 1.11B Dec/2025
J&J USD 192.82B 573M Sep/2025
Masimo USD 1.82B 585.1M Sep/2025
Medtronic USD 90.97B 708M Jun/2025
Merit Medical Systems USD 2.63B 44.95M Sep/2025
Olympus JPY 1.38T 56.13B Sep/2025
ResMed USD 8.5B 195.02M Dec/2025
Smith & Nephew USD 10.69B 150M Dec/2025
Steris USD 10.41B 5.7M Sep/2025
Stryker USD 47.84B 787M Dec/2025
Tandem Diabetes Care USD 874.65M 1.08M Sep/2025
Teleflex USD 7.87B 496.72M Sep/2025
Zimmer Biomet Holdings USD 23.49B 622.9M Sep/2025